Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price, News & Analysis

Company Overview

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Key Stats

• Today's Range: $24.90 to $25.21
• 50-Day Range: $25.11 to $29.51
• 52-Week Range: $17.93 to $30.46
• Volume: 416,588 shs
• Average Volume: 248,263 shs
• Market Capitalization: N/A
• P/E Ratio: 22.25
• Dividend Yield: 2.29%
• Price Target: $27.80
• Consensus Rating: Hold

Fresenius Medical Care AG & Co. KGaA Stock Analysis - MarketRank™

Fresenius Medical Care AG & Co. KGaA scored higher than 71% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Hold

Consensus Rating

Fresenius Medical Care AG & Co. KGaA has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Fresenius Medical Care AG & Co. KGaA has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 5.0 / 5
• Proj. Earnings Growth: 27.15%

Earnings Growth

Earnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 27.15% in the coming year, from $1.51 to $1.92 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 22.25, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.03.

Price to Earnings Ratio vs. Sector

The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 22.25, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.15.

Price to Earnings Growth Ratio

Fresenius Medical Care AG & Co. KGaA has a PEG Ratio of 0.54. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Fresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 3.55%, indicating that investor sentiment is decreasing.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Fresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 2.27%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Fresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 50.89%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 29.69% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 3.55%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: N/A

News Sentiment

Fresenius Medical Care AG & Co. KGaA has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.

Search Interest

Only 1 people have searched for FMS on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

1 people have added Fresenius Medical Care AG & Co. KGaA to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Fresenius Medical Care AG & Co. KGaA insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 8.37% of the stock of Fresenius Medical Care AG & Co. KGaA is held by institutions.

FMS Stock Analysis - Frequently Asked Questions

How have FMS shares performed this year?

Fresenius Medical Care AG & Co. KGaA's stock was trading at $22.64 on January 1st, 2025. Since then, FMS shares have increased by 10.1% and is now trading at $24.9180.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) released its earnings results on Tuesday, May, 6th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.01. The business had revenue of $5.54 billion for the quarter, compared to analyst estimates of $4.71 billion. Fresenius Medical Care AG & Co. KGaA had a trailing twelve-month return on equity of 6.25% and a net margin of 3.18%.
Read the conference call transcript.

Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?

The following companies are subsidiaries of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.

Who are Fresenius Medical Care AG & Co. KGaA's major shareholders?

Top institutional investors of Fresenius Medical Care AG & Co. KGaA include Pzena Investment Management LLC (2.50%), Hennessy Advisors Inc. (0.07%), Envestnet Asset Management Inc. and Moran Wealth Management LLC (0.03%).

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care AG & Co. KGaA investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Energy Transfer (ET), AbbVie (ABBV), GE Aerospace (GE) and Adobe (ADBE).

Company Calendar

• Last Earnings: 5/06/2025
• Record date for 6/6 Dividend: 5/23/2025
• Ex-Dividend for 6/6 Dividend: 5/23/2025
• Dividend Payable: 6/06/2025
• Today: 8/04/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Healthcare
• Current Symbol: NYSE:FMS
• CIK: 1333141
• Web: www.freseniusmedicalcare.com
• Phone: (496) 172-6090
• Fax: 49-6172-609-2301
• Employees: 1,384
• Year Founded: 1912

Price Target and Rating

• Average Price Target for Fresenius Medical Care AG & Co. KGaA: $27.80
• High Price Target: $30.00
• Low Price Target: $25.60
• Potential Upside/Downside: +11.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.12
• Trailing P/E Ratio: 22.25
• Forward P/E Ratio: 16.50
• P/E Growth: 0.54
• Net Income: $582.08 million
• Net Margins: 3.18%
• Pretax Margin: 5.91%
• Return on Equity: 6.25%
• Return on Assets: 2.88%

Debt

• Debt-to-Equity Ratio: 0.40
• Current Ratio: 1.46
• Quick Ratio: 1.08

Sales & Book Value

• Annual Sales: $20.63 billion
• Price / Sales: N/A
• Cash Flow: $4.83 per share
• Price / Cash Flow: 5.16
• Book Value: $29.08 per share
• Price / Book: 0.86

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Optionable
• Beta: 0.87